Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)
Clinical trial NCT05682326 · COMPLETED
Trial details
- NCT number
- NCT05682326
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2024-10-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.